1. Home
  2. TNET vs TVTX Comparison

TNET vs TVTX Comparison

Compare TNET & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriNet Group Inc.

TNET

TriNet Group Inc.

HOLD

Current Price

$37.83

Market Cap

1.7B

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$27.62

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNET
TVTX
Founded
1988
N/A
Country
United States
United States
Employees
2700
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
3.3B
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
TNET
TVTX
Price
$37.83
$27.62
Analyst Decision
Hold
Strong Buy
Analyst Count
5
13
Target Price
$65.80
$36.25
AVG Volume (30 Days)
556.3K
1.1M
Earning Date
05-15-2026
05-11-2026
Dividend Yield
2.96%
N/A
EPS Growth
N/A
92.89
EPS
3.20
N/A
Revenue
$5,010,000,000.00
N/A
Revenue This Year
N/A
$44.62
Revenue Next Year
$3.30
$32.09
P/E Ratio
$11.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.67
$12.91
52 Week High
$88.56
$42.13

Technical Indicators

Market Signals
Indicator
TNET
TVTX
Relative Strength Index (RSI) 39.97 41.70
Support Level $33.67 $26.72
Resistance Level $39.10 $31.47
Average True Range (ATR) 1.74 1.06
MACD 0.81 0.00
Stochastic Oscillator 70.31 32.26

Price Performance

Historical Comparison
TNET
TVTX

About TNET TriNet Group Inc.

Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: